Immune-correlates analysis of an HIV-1 vaccine efficacy trial BF Haynes, PB Gilbert, MJ McElrath, S Zolla-Pazner, GD Tomaras, ... New England Journal of Medicine 366 (14), 1275-1286, 2012 | 2078 | 2012 |
Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor LA Lasky, G Nakamura, DH Smith, C Fennie, C Shimasaki, E Patzer, ... Cell 50 (6), 975-985, 1987 | 1136 | 1987 |
Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160 PW Berman, TJ Gregory, L Riddle, GR Nakamura, MA Champe, JP Porter, ... Nature 345 (6276), 622-625, 1990 | 806 | 1990 |
Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein LA Lasky, JE Groopman, CW Fennie, PM Benz, DJ Capon, DJ Dowbenko, ... Science 233 (4760), 209-212, 1986 | 530 | 1986 |
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial PB Gilbert, ML Peterson, D Follmann, MG Hudgens, DP Francis, ... The Journal of infectious diseases 191 (5), 666-677, 2005 | 468 | 2005 |
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination NL Yates, HX Liao, Y Fong, A DeCamp, NA Vandergrift, WT Williams, ... Science translational medicine 6 (228), 228ra39-228ra39, 2014 | 467 | 2014 |
Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion RF Siliciano, T Lawton, C Knall, RW Karr, P Berman, T Gregory, ... Cell 54 (4), 561-575, 1988 | 453 | 1988 |
Variable and conserved neutralization antigens of human immunodeficiency virus RA Weiss, PR Clapham, JN Weber, AG Dalgleish, LA Lasky, PW Berman Nature 324 (6097), 572-575, 1986 | 385 | 1986 |
Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials DC Montefiori, C Karnasuta, Y Huang, H Ahmed, P Gilbert, MS De Souza, ... The Journal of infectious diseases 206 (3), 431-441, 2012 | 358 | 2012 |
T cells can present antigens such as HIV gp120 targeted to their own surface molecules A Lanzavecchia, E Roosnek, T Gregory, P Berman, S Abrignani Nature 334 (6182), 530-532, 1988 | 353 | 1988 |
Genetic variants of HIV-1 in Thailand FE McCUTCHAN, PA Hegerich, TP Brennan, P Phanuphak, P Singharaj, ... AIDS research and human retroviruses 8 (11), 1887-1895, 1992 | 340 | 1992 |
Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins S Weikert, D Papac, J Briggs, D Cowfer, S Tom, M Gawlitzek, J Lofgren, ... Nature biotechnology 17 (11), 1116-1121, 1999 | 307 | 1999 |
Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization DC Bou-Habib, G Roderiquez, T Oravecz, PW Berman, P Lusso, ... Journal of virology 68 (9), 6006-6013, 1994 | 295 | 1994 |
Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial R Gottardo, RT Bailer, BT Korber, S Gnanakaran, J Phillips, X Shen, ... PloS one 8 (9), e75665, 2013 | 257 | 2013 |
Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1. WA Werther, TN Gonzalez, SJ O'Connor, S McCabe, B Chan, T Hotaling, ... Journal of immunology (Baltimore, Md.: 1950) 157 (11), 4986-4995, 1996 | 226 | 1996 |
Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120. PW Berman, JE Groopman, T Gregory, PR Clapham, RA Weiss, ... Proceedings of the National Academy of Sciences 85 (14), 5200-5204, 1988 | 208 | 1988 |
Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing (" native" gel) system of polyacrylamide gel electrophoresis coupled with … GH Cohen, VJ Isola, J Kuhns, PW Berman, RJ Eisenberg Journal of virology 60 (1), 157-166, 1986 | 203 | 1986 |
Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D PW Berman, T Gregory, D Crase, LA Lasky Science 227 (4693), 1490-1492, 1985 | 199 | 1985 |
Experimental myasthenia gravis. A murine system. PW Berman, J Patrick The Journal of experimental medicine 151 (1), 204-223, 1980 | 189 | 1980 |
Localization of epitopes of herpes simplex virus type 1 glycoprotein D RJ Eisenberg, D Long, M Ponce de Leon, JT Matthews, PG Spear, ... Journal of Virology 53 (2), 634-644, 1985 | 183 | 1985 |